Our results raise the need for further investigations to establish any association between IFN neutralizing autoantibodies and development of diabetes before embarking on in-depth investigations on targeting type 1 IFNs for the treatment or prevention of type 1 diabetes. The gene discussed is IFNA1; the disease is diabetes mellitus.